Aigner E - Search Results

1

The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease.

Feldman A, Aigner E, Weghuber D, Paulmichl K. Feldman A, et al. Among authors: aigner e. Biomed Res Int. 2015;2015:287401. doi: 10.1155/2015/287401. Epub 2015 Jul 26. Biomed Res Int. 2015. PMID: 26273604 Free PMC article. Review.

2

The Association between Helicobacter pylori and Colorectal Neoplasia.

Wernly S, Semmler G, Flamm M, Rezar R, Aigner E, Datz C, Wernly B. Wernly S, et al. Among authors: aigner e. Med Princ Pract. 2023;32(1):77-85. doi: 10.1159/000528794. Epub 2022 Dec 29. Med Princ Pract. 2023. PMID: 36580903 Free PMC article.

3

Prevalence of Subclinical Cardiovascular Disease in Patients with Non-Alcoholic-Fatty Liver Disease: Analysis of the Paracelsus 10.000 Cohort Study.

Koutny F, Aigner E, Datz C, Gensluckner S, Maieron A, Mega A, Iglseder B, Langthaler P, Frey V, Paulweber B, Trinka E, Wernly B. Koutny F, et al. Among authors: aigner e. Med Princ Pract. 2023 Sep 7;32(4-5):272-80. doi: 10.1159/000533909. Online ahead of print. Med Princ Pract. 2023. PMID: 37678174 Free PMC article.

4

Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.

Aigner E, Theurl I, Haufe H, Seifert M, Hohla F, Scharinger L, Stickel F, Mourlane F, Weiss G, Datz C. Aigner E, et al. Gastroenterology. 2008 Aug;135(2):680-8. doi: 10.1053/j.gastro.2008.04.007. Epub 2008 Apr 15. Gastroenterology. 2008. PMID: 18505688

5

A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease.

Aigner E, Strasser M, Haufe H, Sonnweber T, Hohla F, Stadlmayr A, Solioz M, Tilg H, Patsch W, Weiss G, Stickel F, Datz C. Aigner E, et al. Am J Gastroenterol. 2010 Sep;105(9):1978-85. doi: 10.1038/ajg.2010.170. Epub 2010 Apr 20. Am J Gastroenterol. 2010. PMID: 20407430

6

Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia.

Stadlmayr A, Aigner E, Steger B, Scharinger L, Lederer D, Mayr A, Strasser M, Brunner E, Heuberger A, Hohla F, Steinwendner J, Patsch W, Datz C. Stadlmayr A, et al. Among authors: aigner e. J Intern Med. 2011 Jul;270(1):41-9. doi: 10.1111/j.1365-2796.2011.02377.x. Epub 2011 Apr 25. J Intern Med. 2011. PMID: 21414047 Free article.

7

Iron homeostasis in the metabolic syndrome.

Datz C, Felder TK, Niederseer D, Aigner E. Datz C, et al. Among authors: aigner e. Eur J Clin Invest. 2013 Feb;43(2):215-24. doi: 10.1111/eci.12032. Epub 2013 Jan 7. Eur J Clin Invest. 2013. PMID: 23289518 Review.

8

Obesity as an emerging risk factor for iron deficiency.

Aigner E, Feldman A, Datz C. Aigner E, et al. Nutrients. 2014 Sep 11;6(9):3587-600. doi: 10.3390/nu6093587. Nutrients. 2014. PMID: 25215659 Free PMC article. Review.

9

25OH-Vitamin D3 Levels in Obesity and Metabolic Syndrome-Unaltered in Young and not Correlated to Carotid IMT in All Ages.

Mangge H, Zelzer S, Meinitzer A, Stelzer I, Schnedl WJ, Weghuber D, Fuchs D, Postolache TT, Aigner E, Datz C, Reininghaus EZ. Mangge H, et al. Among authors: aigner e. Curr Pharm Des. 2015;21(17):2243-9. doi: 10.2174/1381612821666150105160931. Curr Pharm Des. 2015. PMID: 25557634 Clinical Trial.

10

Hepatic steatosis in Wilson disease--Role of copper and PNPLA3 mutations.

Stättermayer AF, Traussnigg S, Dienes HP, Aigner E, Stauber R, Lackner K, Hofer H, Stift J, Wrba F, Stadlmayr A, Datz C, Strasser M, Maieron A, Trauner M, Ferenci P. Stättermayer AF, et al. Among authors: aigner e. J Hepatol. 2015 Jul;63(1):156-63. doi: 10.1016/j.jhep.2015.01.034. Epub 2015 Feb 9. J Hepatol. 2015. PMID: 25678388

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

140 results

Search Page